B cells: deplete, repopulate, vaccinate
- PMID: 35110747
- PMCID: PMC8808272
- DOI: 10.1038/s41584-022-00754-y
B cells: deplete, repopulate, vaccinate
Abstract
In addition to the time since rituximab treatment, new results show that B cell reconstitution is important for response to vaccination in patients with autoimmune rheumatic disease.
Comment on
-
B Cell Reconstitution Is Strongly Associated With COVID-19 Vaccine Responsiveness in Rheumatic Disease Patients Who Received Treatment With Rituximab.Arthritis Rheumatol. 2022 May;74(5):776-782. doi: 10.1002/art.42034. Epub 2022 Mar 15. Arthritis Rheumatol. 2022. PMID: 34908241
-
Rituximab Impairs B Cell Response But Not T Cell Response to COVID-19 Vaccine in Autoimmune Diseases.Arthritis Rheumatol. 2022 Jun;74(6):927-933. doi: 10.1002/art.42058. Epub 2022 Mar 29. Arthritis Rheumatol. 2022. PMID: 34962357 Free PMC article.
-
B Cell Numbers Predict Humoral and Cellular Response Upon SARS-CoV-2 Vaccination Among Patients Treated With Rituximab.Arthritis Rheumatol. 2022 Jun;74(6):934-947. doi: 10.1002/art.42060. Epub 2022 Apr 17. Arthritis Rheumatol. 2022. PMID: 34962360 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
